Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CTCPROTEOMIC

Financiado

Cerrado

Single cell proteomics for studying circulating tumor cells and monitor disease...

Single cell proteomics for studying circulating tumor cells and monitor disease progression on breast cancer patients "The planned research is aimed at the proteomic analysis at single cell level for circulating tumor cells (CTCs), as these cells shed from the primary tumor site and are identified in transit within the bloodstream of cancer patie... ver más

02/09/2014

IMPERIAL COLLEGE O...

200K€

Presupuesto del proyecto: 200K€

Líder del proyecto

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND ME... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-09-02 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

IMPERIAL COLLEGE OF SCIENCE...

0.00€ | Lider

Proyectos interesantes

PROTBIOFLUID

Medical Technol...

Data Science

355K€ Cerrado

CANOMICS

Medical Technol...

Data Science

86K€ Cerrado

PROTEOMICAN

Medical Technol...

Data Science

2M€ Cerrado

ProACCT

Medical Technol...

Data Science

2M€ Cerrado

IMPED

Medical Technol...

Data Science

225K€ Cerrado

Spatial Proteomics

Medical Technol...

Data Science

1M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND ME... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 200K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "The planned research is aimed at the proteomic analysis at single cell level for circulating tumor cells (CTCs), as these cells shed from the primary tumor site and are identified in transit within the bloodstream of cancer patients with metastatic degree of the disease. The proposed work have an highly multidisciplinar approach to engage the central challenge of our proposal, combining proteomic analysis, microfluidic antibody capture chips and a ‘full optical’ platform which accounts for cell manipulation, cell lysis and protein’s quantification with a level of sensitivity down to proteins copy number. Milestone of the project in carrying out analysis at single cell level, is the comprehensive proteomic study of cell-to-cell variations for the expression of cancer biomarkers, which ultimately led to the heterogeneity, complexity and evolution at phenotypic level of the disease. By the analysis of circulating tumour cells isolated from the peripheral blood of breast cancer patients, we will focus the attention on the quantification of the free form of estrogen receptor and its phoshpotypes, as a unvaluable biomarker directly involved in cellular proliferation and actually targeted by endocrine therapies in clinical practice. Thus, estrogen receptor will be embedded in a platform for multiplex proteomic analysis at single cell level with other four biomarkers. Information achieved by analysis of CTCs will be directly correlate with the status of cells at primary tumor site and the overall status of the disease. Results are expected to provide new insights into tumour cell biology and will offer a new non-invasive tool to monitor the evolution and the progression of the disease, as well the response to therapies during treatment and follow-up of patients."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores